Aloe Supplement Makes Drug Claims, Touts HHS 'Certificate' Of Approval
This article was originally published in The Rose Sheet
Executive Summary
The FDA ORA Chicago District's lengthy inspection at a Illinois firm in May, June and July 2015 and a review of its website found drug claims including "helps control diabetes."
You may also be interested in...
FDA Salmonella Finding Triggers Recall Of Nopalina Flax Seed Fiber Products
Waukegan, IL-based Salud Natural Entrepreneur, Inc. is recalling lots of Nopalina Flax Seed Fiber powder and capsules after FDA tested an ingredient used in their manufacture and identified three types of Salmonella bacteria. The agency issued a warning letter to the firm in April 2016 for violations including GMP failures.
Aloe Farms' Claims, GMP Practices Rub FDA The Wrong Way
The firm's violative label claims include Aloe Vera Gel "cures everything" and its branding mistakes include failing to list all ingredients for its Aloe Capsules and Original Whole Leaf Aloe Vera Capsules.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”